Harry Clarke to Prostatic Hyperplasia
This is a "connection" page, showing publications Harry Clarke has written about Prostatic Hyperplasia.
Connection Strength
0.395
-
Combination 5-alpha-reductase inhibitors and alpha-blockers for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Curr Urol Rep. 2008 Jul; 9(4):291-4.
Score: 0.294
-
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003 Dec 18; 349(25):2387-98.
Score: 0.054
-
Recruitment for a clinical trial of drug treatment for benign prostatic hyperplasia. Urology. 2002 Jan; 59(1):63-7.
Score: 0.047